⌘K

Login Start Free

Home/Filings/4/0001144204-15-021876

4//SEC Filing

CASI Pharmaceuticals, Inc. 4

Accession 0001144204-15-021876

CIK 0000895051operating

View on SEC.gov Company Profile

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 5:53 PM ET

Size

5.4 KB

Accession

0001144204-15-021876

Insider Transaction Report

Form 4

Period: 2015-04-06

CASI Pharmaceuticals, Inc.CASI

Chief Executive Officer

Transactions

Award
Stock Options(Right to Buy)
2015-04-06+225,000→ 225,000 total
Exercise: $1.41Exp: 2025-04-06→ Common Stock (225,000 underlying)

Footnotes (1)

[F1]The stock options vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.

Documents

1 file

4
v406875_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

CASI Pharmaceuticals, Inc.

CIK 0000895051

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000895051

Filing Metadata

Form type: 4
Filed: Apr 7, 8:00 PM ET
Accepted: Apr 8, 5:53 PM ET
Size: 5.4 KB

View on SEC.gov